The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IMMUNONET: A multicenter, open-label, proof-of-concept phase II trial evaluating NP137 as add-on therapy in advanced/metastatic solid tumors treated with standard immunotherapies.
 
Jérôme Fayette
Honoraria - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Sanofi
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Merus NV; Seagen; Takeda
Travel, Accommodations, Expenses - Merck Serono; Merck Sharp & Dohme
 
Eve-Marie Neidhardt
Consulting or Advisory Role - Pierre Fabre (Inst)
Travel, Accommodations, Expenses - Le cancer.fr; Pierre Fabre
 
Victoria Ferrari
No Relationships to Disclose
 
Mona Amini Adle
Honoraria - Alexion Pharmaceuticals; BMS GmbH & Co. KG; MSD; Novartis; Pierre FABRE
Consulting or Advisory Role - Pierre Fabre
Research Funding - BMSi
Travel, Accommodations, Expenses - Alexion Pharmaceuticals; MSD; Pierre Fabre
 
Jean-Pierre Delord
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Novartis (Inst); Pierre Fabre (Inst); Roche/Genentech (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); MSD Oncology (Inst); Transgene (Inst)
 
David Pérol
Honoraria - AstraZeneca; Bayer; Boehringer Ingelheim; Brenus Pharma; Bristol Myers Squibb Foundation; DAIICHI SANKYO; Gilead Sciences; IPSEN; Janssen; Lilly; MSD; Novartis; Pfizer; TAKEDA
Travel, Accommodations, Expenses - Novartis; Roche
 
Gwenaelle Garin
No Relationships to Disclose
 
Camille Schiffler
No Relationships to Disclose
 
Stephane Depil
Employment - ErVimmune
Leadership - ErVimmune
Stock and Other Ownership Interests - ErVimmune
Research Funding - ErVimmune
Patents, Royalties, Other Intellectual Property - ErVimmune
 
Nerea Muñoz Unceta
No Relationships to Disclose
 
Elise Georges
Employment - Netris Pharma
 
Esma Saada
No Relationships to Disclose